Eli Lilly (LLY)

The drugmaker is getting on the AI train in ways that could move the needle down the road.

Eli Lilly has more to offer than some investors realize.

Hims & Hers stock rallied on Friday on a major regulatory update and bullish analyst note. Here’s how high HIMS shares could realistically fly through the end of 2026.

Eli Lilly shares sink as data shows Foundayo trailing Novo’s oral Wegovy. But there’s reason to consider buying LLY shares on the dip today.

This pharma stock is cheap for a reason.

This space stock could literally go "to the moon."

With more focus on nuclear energy, companies connected to nuclear power could be strong long-term investments.

Most investors currently see the glass on this stock as being half-empty. Analysts, however, still view the glass as at least half-full.

Eli Lilly is a giant in the weight-loss drug realm, and it's aiming to grow more.

You get the upside of the sector, while minimizing some of the risks.

The weight loss drug market may reach almost $100 billion in a few years.

High hopes for a freshly approved drug might not be realized, if early data is any indication.

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.6% in the afternoon session after disappointing weekly prescription number...

Major M&A deals this week include Eli Lilly buys Kelonia for $7 billion, Honeywell sells PSS to Brady Corp., KSL buys Invited Clubs.

Eli Lilly stock skidded early Friday as Novo Nordisk's oral Wegovy continued to outpace Lilly's new obesity pill, Foundayo.

Young adults with median earnings can build sizable portfolios by retirement by regularly purchasing shares of the Vanguard S&P 500 Growth ETF.

Let’s dig into the relative performance of Merck (NYSE:MRK) and its peers as we unravel the now-completed Q4 branded pharmaceuticals earnings season. Looking...

Federated Hermes delivers asset management solutions across equity, fixed income, and money market funds to a diverse client base.

Amazon is expanding into integrated weight-loss care with a scalable healthcare model. Can this expansion meaningfully drive AMZN stock upside?

Novo Nordisk stock has been stuck in a downward spiral for quite some time.

Hims & Hers Health can now connect its customers with self-pay prices for Eli Lilly's weight-loss drugs.

Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.

These companies offer a clear path to sustained earnings growth.